The Katayama syndrome in Saudis.

Area of Science:

• Tropical Medicine
• Infectious Diseases
• Parasitology

Background:

• Schistosomiasis is a parasitic disease prevalent in endemic areas.
• Katayama syndrome represents the acute febrile illness associated with Schistosoma mansoni infection.
• Early diagnosis and treatment are crucial for managing parasitic infections.

Purpose of the Study:

• To investigate the clinical presentation and treatment outcomes of Katayama syndrome in pediatric patients.
• To evaluate the efficacy of praziquantel and oxamniquine in treating acute schistosomiasis.
• To determine the impact of early treatment on disease progression and patient recovery.

Main Methods:

• Case study of five Saudi boys with suspected schistosomiasis exposure.
• Clinical diagnosis of Katayama syndrome based on symptoms, eosinophilia, and parasite eggs in feces.
• Serological testing for schistosome exposure.
• Treatment with praziquantel or oxamniquine.
• Monitoring of clinical symptoms, eosinophil counts, and liver function tests.

Main Results:

• All five patients presented with symptoms consistent with Katayama syndrome after exposure to infected water.
• Parasitological and serological evidence confirmed Schistosoma mansoni infection.
• Treatment with praziquantel or oxamniquine led to rapid clinical improvement within 3-6 days.
• Eosinophilia decreased, and liver function normalized within 3 months post-treatment.

Conclusions:

• Early treatment of Katayama syndrome with anti-schistosomal drugs significantly alters the acute illness course.
• Praziquantel and oxamniquine are effective in treating acute schistosomiasis, leading to rapid symptom resolution and recovery.
• Prompt intervention halts disease progression and prevents long-term complications.